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Pfeiffer Syndrome is as rare as Apert syndrome in the Western population. This 
condition is very rare in the Asian population. At the best of our knowledge 
this is the first genetically proven case report from Iran. The authors report with 
a review of literature, the case of a infant with Pfeiffer syndrome, manifested 
by Lacunar skull, ventriculomegaly, bicoronal craniosynostosis,frontal bossing, 
shallow orbits, parrot-like nose, umbilical hernia, broad and medially deviated 
great toes.
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Introduction
Pfeiffer syndrome (PS) is a rare autosomal dominant congenital disorder, originally 
described by Pfeiffer in 1964, and is characterized by an acrocephalic skull, regressed 
midface, syndactyly of hands and feet, and broad thumbs and big toes, with a wide 
range of variable severity(1-6). PS is known to be caused by mutations in exons IIIa 
or IIIc of the fibroblast growth factor receptor (FGFR) 2 or FGFR 1 gene(7-10). We 
report with a review of literature, probably the first infant in Iran with genetically 
proven PS who had bicoronal craniosynostosis, frontal bossing, shallow orbits, 
parrot-like nose, umbilical hernia, broad and medially deviated great toes.
Case Report
A male infant, aged 27 months was referred to Endocrinology and Metabolic diseases 
clinic of Mofid Children’s hospital for further evaluation. This infant was born 
from a 17-year-old healthy primigravid Iranian mother. The infant was delivered 
by cesarean section because of diminished amniotic fluid(oligohydramnios) at 38 
weeks gestation . He was 2.9 kg in weight (10-25 percentile), the head circumference 
was 35 cm (25-50 percentile), and the height at birth was 50 cm (50 percentile). His 
parents are both phenotypically normal and nonconsanguineous. 
Upon birth, the infant demonstrated bilaterally fused coronal sutures, mild proptosis, 
and maxillary hypoplasia. There was no deformity or motion limitation of bilateral 
elbows or shoulder joints. The infant demonstrated evidence of icterus and need for 
phototherapy in neonatal ward for 3 days.
At four months of age, the infant was referred to neurosurgery clinic of our 
hospital for evaluation of macrocephaly, exophthalmia, anterior fontanel bulging 
and inspiratory stridor. Physical examination revealed a 5 kg in weight infant with 
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dysmorphic features affecting the face and great toes .The 
head circumference was 35 cm. The neurodevelopmental 
status in examination was normal.Computed tomogram 
(CT) studies of the cranium and skull X rays revealed 
craniosynostosis, frontal bossing and shallow orbits. 
Brain CT Scan revealed hydrocephalous, dilated frontal 
horn of third ventricles and normal forth ventricles. He 
did not have any abnormality upon abdominopelvic 
sonographic examination. Echocardiography was also 
normal. The patient had a medium pressure VP-Shunt 
insertion at 18 weeks of age and a sagital suturectomy at 
13 months of age, and was planned for second surgical 
correction of craniosynostosis, followed by additional 
correction procedure for the craniofacial anomalies at 
a later date. Molecular analysis of the patient revealed 
a heterozygous C342R mutation in exone 10 and a 
missense T to C in mRNA. Further studies on such 
sporadic cases recommended enhancing the molecular 
information.
Discussion 
The exact incidence of PS is unknown, but is expected to 
be 1 in every 100,000 births in the Western population, 
and approximately 60 cases to date have been reported 
in the past world-wide literature(11,12). However, it is 
rarer in Asian population: only cases were reported in 
Japan(13,14) and in Korea(3) .
Cohen(15) in 1993 classified this syndrome into 3 
clinical subtypes and suggested that these subtypes might 
not be classified as separate entities, even though these 
classifications have important diagnostic and prognostic 
implications. The classic PS is designated type I. Type II 
consists of a cloverleaf skull with Pfeiffer hands and feet, 
together with ankylosis of the elbows. Type III is similar 
to type II without the cloverleaf skull. In type III PS, 
ocular proptosis is severe, and the anterior cranial base 
is markedly short. Various visceral malformations have 
been found in association with type III 15. Early demise 
is characteristic of both types II and III, which to date 
has been reported to occur only as sporadic cases(10,12). 
Clinical manifestations of this patient appeared to fit into 
subtype I according to Cohen’s clinical classification of 
PS.
Pfeiffer syndrome is most often associated with 
turricephaly. The eyes are prominent and widely spaced, 
and the thumbs and great toes are short and broad. Partial 
soft tissue syndactyly may be evident(2,4). The etiology 
for this syndrome is autosomal dominant or fresh 
mutations in type I conditions, and sporadic in types II 
and III. PS is genetically heterogeneous(7,121).
Mutations of the fibroblast growth factor receptor (FGFR) 
gene family have been shown to be associated with 
phenotypically specific types of craniosynostosis(2,4).
Mutations of the FGFR1 gene located on chromosome 
8 result in Pfeiffer syndrome; a similar mutation of 
the FGFR2 gene causes Apert syndrome. Identical 
mutations of the FGFR2 gene may result in both Pfeiffer 
and Crouzon phenotypes(2,4). The human FGFR2 gene 
is located on long (q) arm of chromosome 10 between 
positions 25.3 and 26 contains 20 exons. The known 
mutation spectrum of FGFR2 has remained essentially 
unchanged since the review by Wilkie. More than 20 
FGFR2 mutations that cause Pfeiffer syndrome have 
been identified. Several of these mutations change the 
number of cysteine amino acids (a particular protein 
buinding block) in a critical region of the FGFR2protein 
known as IgIII domain. The remaining mutations affect 
amino acids other than cysteine or result in an FGFR2 
protein that is missing one or more aminoacids. These 
mutations appear to overstimulate signaling by FGFR2 
protein, which promotes premature fusion of bones in the 
skull, hands and feet(14,24). These mutations are related 
to the old age of parents, especially the father, because 
these mutations are suspected to confer a selective 
advantage to survival of sperm(16). Usually, the parents 
are not affected and the risk for future children of that 
couple is minimal. The offspring of a patient with PS 
have a 50-60% chance of inheriting the syndrome due to 
the dominant characteristics of this gene.
Each of the genetic syndromes poses a risk of additional 
anomalies, including hydrocephalus, increased 
intracranial pressure (ICP), papilledema, optic 
atrophy due to abnormalities of the optic foramina, 
respiratory problems secondary to a deviated nasal 
septum or choanal atresia, and disorders of speech and 
deafness(2,4,6,18,19). Congenital anomalies of the 
upper airway are clearly an important cause of morbidity 
and mortality in PS type II and III but are rare in PS type 
I(17). PS may involve craniosynostosis that is most often 
of the coronal and lambdoid, and occasionally sagittal 
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sutures. Craniectomy is mandatory for management 
of increased ICP, and a multidisciplinary craniofacial 
team is essential for the long-term follow-up of affected 
children. Craniosynostosis may be surgically corrected 
with good outcomes and relatively low morbidity and 
mortality, especially for nonsyndromic infants(4). The 
most common features of the face are regressed mid-
face and shallow orbits, which may be present at birth 
but sometimes become more evident as the childhood 
progresses. Underdeveloped maxillary bone of the face 
results in very shallow orbits and exophthalmos or 
proptosis. The shallow orbits and proptosis may lead 
to damage of the cornea from dryness, or exposure 
keratosis. Maxillary hypoplasia also results in a small 
larynx and pharynx behind the nose and mouth. This 
restricts the passage of air into the trachea and lungs and 
causes respiratory distress, particularly at night when 
snoring and snuffling can interrupt sleep. Similarly, the 
passage of food is restricted, and regurgitation may result 
in aspiration of food into the lungs(1). 
The hands and feet in PS are involved to variable 
degree(20-22). The thumbs and big toes are broad and 
deviated radially. Patient may have mild soft tissue 
webbing of syndactyly between the second, third, and 
fourth digits of eitheror both hands and feet. The digits 
may be short and misshapen.
Other anomalies in PS could include a cleft palate, 
choanal atresia, tracheo- and broncho-malacia, tracheal 
stenosis(17), cloverleaf skull, fused vertebrae, Arnold-
Chiari malformation, hydrocephalus, and imperforate 
anus. After birth, seizures and mental retardation may 
develop.
The above case presented by authors is in accordance 
with type I Pfeiffer syndrome, because the infant had 
a craniosynostosis only of bilateral coronal suture and 
demonstrated broad and medially deviated great toes 
that are characteristic of PS. The diagnosis of the Apert 
syndrome is appropriate rather than PS if a patient has 
broad thumbs and syndactyly with bony fusion(20) 
or syndactyly of the second, third and fourth web 
spaces(22). However, clinical differential diagnosis 
has been confusing until now in relation with genetic 
findings because Pfeiffer mutation has been reported to 
occur in a patient with Apert syndrome(23), and identical 
mutations in the FGFR2 gene could cause both PS and 
Crouzon syndrome phenotypes(24) as illustrated by the 
demonstration of both phenotypes of Apert and of PS in 
experimental mice(25). Some authors have attempted to 
revise the classification for Apert, Carpenter, Crouzon, 
Jackson-Weiss, Pfeiffer and Saethre-Chotzen syndromes 
on a genetic basis. Because of widely intermingling 
of phenotypic expressions or genetic sharing of the 
same mutation, as yet there is no definite evidence that 
phenotypic expressions correlate accurately with genetic 
mutations(13,23-27). This is probably because the gene 
that controls these expressions has not been elucidated 
to date(28).
The prognosis depends on the severity of associated 
anomalies, mainly the severity of the central nervous 
system compromise. Patients with type I syndrome 
have, in general, a good prognosis. Patients with types II 
and III usually expire early in infancy or childhood even 
though some may survive with aggressive medical and 
surgical management(8). 
Multiple staged surgeries are the general treatment 
plan for patients with PS. In the first year of life it is 
preferred to release the synostotic sutures of the skull 
to allow adequate cranial volume and thus allowing for 
brain growth and expansion. The patient had a medium 
pressure VP-Shunt insertion at    18 weeks of age and a 
sagital suturectomy at 13 months of age and a bicoronal 
suturectomy at 23 months of age, the additional skull 
expansion surgery would be repeated as the child grows 
.Although significant malformation of the toes are 
present, usually these function adequately and do not 
require the surgical correction. Mid-facial advancement 
may be performed in order to provide an adequate orbital 
volume and reduce the exophthalmos, and to correct 
the dental occlusion to achieve appropriate functional 
position, but these procedures are not common in patients 
with PS. 
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Figure 1. Frontal photograph of patient 4months after the 
bicoronal suturectomy, showing the proptosis but normal 
head circmference.
Figure 2. Lateral photograph of patient 4months after the 
bicoronal suturectomy, showing the proptosis.
Figure 3. Skull X ray of patient 4months after the bicoronal 
suturectomy.
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